USD 12 billion
Prostate Cancer Treatment Market Size, Share, Growth Analysis, By Drug(Extruded Chemotherapy, Biological Therapy, Hormone Therapy, and Others), By Distribution Channel(Hospitals Pharmacies, Drug Stores & Retail Pharmacies, and Online Pharmacies), By Region - Industry Forecast 2024-2031
Report ID:
SQMIG35I2244 |
Region:
Global |
Published Date: February, 2024
Pages:
157
|Tables:
64
|Figures:
75
Prostate Cancer Treatment Market Insights
Global Prostate Cancer Treatment Market size was valued at USD 12 billion in 2022 and is poised to grow from USD 13.04 billion in 2023 to USD 25.42 billion by 2031, growing at a CAGR of 8.70% in the forecast period (2024-2031).
The global prostate cancer treatment market offers a dynamic landscape along with important market insights. Prostate cancer, one of the most common cancers in men worldwide, drove the market growth. The primary objective of the global prostate cancer treatment market is to provide advanced and effective treatment for patients diagnosed with prostate cancer.
Several factors drive the market, such as the aging global population, increased awareness, and early diagnosis including prevalence led to new treatments and medications. However, the market faces restraining factors such as high treatment costs and potential side effects associated with prostate cancer treatment, which may restrict its widespread adoption.
Key factors include an aging population, increasing incidence of prostate cancer, increase in pharmaceutical drugs, increasing awareness of prostate cancer treatment, R&D funding by new medical products, improved penetration, emergence of complex pipeline drugs, and availability of new prostate cancer therapies driving the growth of prostate cancer therapeutics market.
Also, the increasing demand for prostate cancer treatment and the use and application of hormonal therapy in non-metastatic castration-resistant (nmCRPC) & metastatic hormone-naive (mHNPC) prostate cancer conditions are other factors contributing to market growth.
Moreover, untapped potentials offered by developing economies offer lucrative opportunities for market growth during the forecast period but longer healing period is expected in underdeveloped economies and weak demand for prostate cancer drugs will hamper the growth of this market.
Challenges in the global prostate cancer treatment market include the need for a more personalized treatment approach, evolving regulatory requirements but significant opportunities in this market through drug targeting drugs accuracy that greatly enhances treatment for individual patients as the market continues to grow, investment in R&D could be seen to increase, leading to more effective and efficient treatments for patients with prostate cancer, and ultimately improve their quality of life and survival.
Market snapshot - 2024-2031
Global Market Size
Largest Segment
Hormone therapy
Fastest Growth
Biological therapy
Growth Rate
8.70% CAGR
Global Prostate Cancer Treatment Market ($ Bn)
Country Share for North America Region (%)
To get more reports on the above market click here to Buy The Report
Prostate Cancer Treatment Market Segmental Analysis
The global prostate cancer treatment market is segmented on the basis of drug, distribution channel, and region. By drug, the market is segmented into chemotherapy, biological therapy, hormone therapy, and others. By distribution channel, the market is segmented into hospitals pharmacies, drug stores & retail pharmacies, and online pharmacies. By region, the market is segmented into North America, Europe, Asia Pacific, Middle East and Africa, and Latin America.
Analysis By Drug
The hormone therapy segment is the largest segment in the global prostate cancer treatment market. Hormone therapy, also known as androgen deprivation therapy, plays an important role in dealing with prostate cancer by reducing levels of male hormones (androgens) in the body, which can promote cancer growth, which is also why it helps. Increased acceptance of hormone therapy makes sense, as it is more tolerable for patients due to its non-invasive nature. Furthermore, its continued increase is underscored by the increasing geriatric population, as prostate cancer is more common in older men. As the aging population continues to expand, the demand for hormone therapy is expected to rise, creating strong market potential
The fastest growing segment in the global prostate cancer treatment market is biological therapeutics. Cell therapy, generally involving the immune system, has gained momentum due to the innovative way of harnessing the immune system and targeting cancer cells. Their rapid growth exhibits groundbreaking research and development efforts that lead to promising new antibodies and quality of life.
Analysis By Distribution Channel
The hospitals and pharmacies stand as the largest segment. This prominent list is not surprising, given that hospitals are the primary sites for the diagnosis and treatment of cancer. They offer comprehensive care under one roof, making them the go-to destinations for prostate cancer treatments. With state-of-the-art hospital pharmacies and a multidisciplinary approach, patients can be provided with immediate access to essential medicines and treatments, ensuring timely intervention and support.
The fastest growing segment in this market is online pharmacies. What makes online pharmacies appealing is their convenience and accessibility. In an age where digitization has changed the way we access healthcare, online pharmacies have gained incredible traction. Patients appreciate the ease of ordering medicines in their home, which are often expensive. This trend is further accelerated by the current global shift towards telemedicine and e-health solutions, which are fueling the growing adoption of online methods for procurement of prostate cancer treatments.
Global Prostate Cancer Treatment Market By Drug
To get detailed analysis on other segments, Request For Free Sample Report
Prostate Cancer Treatment Market Regional Insights
The dominant region in this market is North America. North America’s leadership comes from a high prevalence of prostate cancer, well-established healthcare infrastructure and strong investment in research and development. The region has leading pharmaceutical and biotechnology companies innovating in the treatment of prostate cancer. The presence of many older people also contributes to the search for effective treatment.
The Asia Pacific is expected to be the fastest growing region in the global prostate cancer treatment market. The Asia-Pacific region is witnessing a rapid increase in the incidence of prostate cancer due to changing lifestyles and an aging population. Moreover, increasing health literacy and improved access to health facilities are fueling the demand for advanced prostate cancer treatment in the region. Within the Asia Pacific, emerging countries such as China and India are investing heavily in healthcare infrastructure and research to develop new therapies.
Global Prostate Cancer Treatment Market By Region
- Largest
- Fastest
To know more about the market opportunities by region and country, click here to
Buy The Complete Report
Prostate Cancer Treatment Market Dynamics
Drivers
Increase in prevalence of prostate cancer
- The increasing incidence of prostate cancer can be attributed to several factors, including an aging global population, increasing knowledge and improving diagnostic methods as the world population ages, expectations that the incidence of prostate cancer will increase, as it is a disease that mainly affects older men. Awareness and comprehensive screening programs have led to earlier detection of prostate cancer, resulting in higher reported birth rates These factors underscore the importance of effective treatment and therapy for prostate cancer, and creating new advanced treatment options in the global Stimulating market.
Restraints
Cost & Pricing Pressure
- The global prostate cancer therapeutics market faces significant constraints, with significant challenges and high costs associated with targeted therapies and other immunotherapies. Although these advanced therapies have shown outstanding promise to improve patient outcomes, affordability remains a concern. The costs of targeted therapies and immunotherapies, such as immunosuppressants, can be substantial, placing a significant financial burden on patients and the healthcare variety. This high cost often limits access to these alternative therapies, which can make a difference in care and be beneficial to it. A select few patients worldwide struggle with the need to balance budgets of the burden and, making it necessary to address cost barriers to ensure accurate access to this potentially life-saving therapy for this type of prostate cancer.
Request Free Customization of this report to help us to meet your business objectives.
Prostate Cancer Treatment Market Competitive Landscape
The global prostate cancer treatment market exhibits intense competition with numerous pharmaceutical companies, medical device manufacturers, and research institutes in association with key players in the sector. They invest heavily in R&D to expand their products .In this competitive environment, therapeutic options have grown exponentially, focusing on targeted therapies, immunotherapy, and precision medicine so, and research programs also contribute to the competitive nature of the market, as companies seek to introduce new treatments to the market and differentiate their products based on efficacy, safety, and price .While demand for new effective prostate cancer therapies increases, this competitive environment continues in patient care It is expected to drive innovation and improvement.
Top Player’s Company Profiles
- Ferring Pharmaceuticals Inc. (Switzerland)
- GlaxoSmithKline Plc. (UK)
- Ipsen Pharma (France)
- AstraZeneca plc (UK)
- F. Hoffmann-La Roche AG (Switzerland)
- Astellas Pharma Inc (Japan)
- Johnson & Johnson (US)
- Bayer AG. (Germany)
- Bristol-Myers Squibb Company (US)
- Takeda Pharmaceutical Company Ltd (Japan)
- Amgen Inc. (US)
- Pfizer Inc (US)
- Novartis AG (Switzerland)
- Sanofi (France)
- Merck & Co., Inc (US)
- Eli Lilly and Company (US)
- Gilead Sciences, Inc (US)
- AbbVie Inc (US)
- Celgene Corporation (US)
- Teva Pharmaceutical Industries Ltd (Israel)
Recent Developments
- In March 2022, the U.S. The Food and Drug Administration (FDA) approved Pluvicto (lutetium Lu 177 vipivotide tetraxetan) for the treatment of adult patients with metastatic castration-resistant prostate-specific membrane antigen-positive prostate cancer that has spread to other sites Body available.
- In March 2022, Biopharma announced the launch of camcevi (leuprolide), a 42mg injectable emulsion, for the treatment of adults with advanced prostate cancer. The company continues to provide Accord Connects mobile application access to manage the Camcevi inventory.
- In March 2022, Merck announced a trial to test Keytruda and lynparza in patients with metastatic-resistant prostate cancer who have keylynk-010.
Prostate Cancer Treatment Key Market Trends
- Personalized Medicine in Prostate Cancer Treatment: Personalized medicine in the treatment of prostate cancer constitutes designing treatments based on the individual's particular genetic and molecular characteristics. Genomic examination can pinpoint variations or genetic identifiers among cancer cells, allowing physicians to opt for therapeutic options that have the most possibility of functioning well for that given patient. This increases the accuracy of treatment and reduces the chances of unnecessary measures, potentially diminishing side effects and escalating ultimate outcomes. Biochemical tests like Prostate Health Index (PHI), Oncotype DX Genomic Prostate Score, and Prolaris test are popular in this regard. Examples of targeted remedies that specifically address tumors with changes to the DNA repair process include drugs such as olaparib and rucaparib for the treatment of progressed prostate cancer.
Prostate Cancer Treatment Market SkyQuest Analysis
SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Component types team that Collects, Collates, Coordinates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.
According to our global prostate cancer treatment market analyses, the market is a multifaceted scenario that affects various factors that determine the demand, treatment, and management of this common male cancer. In essence, several key factors influence the growth of this market. Prostate cancer is a common disease, and its prevalence continues to increase, especially due to the aging global population. The medical industry uses a variety of approaches including surgery, radiation therapy, hormone therapy, chemotherapy, immunotherapy, targeted therapy, and precision medicine. The market has made substantial progress, such as PARP inhibitors (e.g., Olaparib) and immune checkpoint inhibitors (e.g., e.g., Pembrolizumab) for the treatment of advanced prostate cancer. etc. Approved and validated new therapies have brought new hope and improved outcomes for patients on these therapies, especially those with specific genetic mutations. Genomic testing and biomarker discovery have become an integral part of this model, helping physicians make informed decisions about the best treatment for each patient. However, challenges remain within the market. The high cost of advanced therapies such as targeted therapies and immunotherapies remains high.
| Report Metric | Details |
|---|---|
| Market size value in 2023 | USD 12 billion |
| Market size value in 2031 | USD 25.42 billion |
| Growth Rate | 8.70% |
| Forecast period | 2024-2031 |
| Forecast Unit (Value) | USD Billion |
| Segments covered |
|
| Regions covered | North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA) |
| Companies covered |
|
| Customization scope | Free report customization with purchase. Customization includes:-
|
To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.
Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share
Table Of Content
Executive Summary
Market overview
- Exhibit: Executive Summary – Chart on Market Overview
- Exhibit: Executive Summary – Data Table on Market Overview
- Exhibit: Executive Summary – Chart on Prostate Cancer Treatment Market Characteristics
- Exhibit: Executive Summary – Chart on Market by Geography
- Exhibit: Executive Summary – Chart on Market Segmentation
- Exhibit: Executive Summary – Chart on Incremental Growth
- Exhibit: Executive Summary – Data Table on Incremental Growth
- Exhibit: Executive Summary – Chart on Vendor Market Positioning
Parent Market Analysis
Market overview
Market size
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- SWOT Analysis
KEY MARKET INSIGHTS
- Technology Analysis
- (Exhibit: Data Table: Name of technology and details)
- Pricing Analysis
- (Exhibit: Data Table: Name of technology and pricing details)
- Supply Chain Analysis
- (Exhibit: Detailed Supply Chain Presentation)
- Value Chain Analysis
- (Exhibit: Detailed Value Chain Presentation)
- Ecosystem Of the Market
- Exhibit: Parent Market Ecosystem Market Analysis
- Exhibit: Market Characteristics of Parent Market
- IP Analysis
- (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
- Trade Analysis
- (Exhibit: Data Table: Import and Export data details)
- Startup Analysis
- (Exhibit: Data Table: Emerging startups details)
- Raw Material Analysis
- (Exhibit: Data Table: Mapping of key raw materials)
- Innovation Matrix
- (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
- Pipeline product Analysis
- (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
- Macroeconomic Indicators
COVID IMPACT
- Introduction
- Impact On Economy—scenario Assessment
- Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
- Revised Market Size
- Exhibit: Data Table on Prostate Cancer Treatment Market size and forecast 2021-2027 ($ million)
- Impact Of COVID On Key Segments
- Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
- COVID Strategies By Company
- Exhibit: Analysis on key strategies adopted by companies
MARKET DYNAMICS & OUTLOOK
- Market Dynamics
- Exhibit: Impact analysis of DROC, 2021
- Drivers
- Opportunities
- Restraints
- Challenges
- Exhibit: Impact analysis of DROC, 2021
- Regulatory Landscape
- Exhibit: Data Table on regulation from different region
- SWOT Analysis
- Porters Analysis
- Competitive rivalry
- Exhibit: Competitive rivalry Impact of key factors, 2021
- Threat of substitute products
- Exhibit: Threat of Substitute Products Impact of key factors, 2021
- Bargaining power of buyers
- Exhibit: buyers bargaining power Impact of key factors, 2021
- Threat of new entrants
- Exhibit: Threat of new entrants Impact of key factors, 2021
- Bargaining power of suppliers
- Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
- Competitive rivalry
- Skyquest special insights on future disruptions
- Political Impact
- Economic impact
- Social Impact
- Technical Impact
- Environmental Impact
- Legal Impact
Market Size by Region
- Chart on Market share by geography 2021-2027 (%)
- Data Table on Market share by geography 2021-2027(%)
- North America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- USA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Canada
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Europe
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Germany
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Spain
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- France
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- UK
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Europe
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Asia Pacific
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- China
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- India
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Japan
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Korea
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of Asia Pacific
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Latin America
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- Brazil
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of South America
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Middle East & Africa (MEA)
- Chart on Market share by country 2021-2027 (%)
- Data Table on Market share by country 2021-2027(%)
- GCC Countries
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- South Africa
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
- Rest of MEA
- Exhibit: Chart on Market share 2021-2027 (%)
- Exhibit: Market size and forecast 2021-2027 ($ million)
KEY COMPANY PROFILES
- Competitive Landscape
- Total number of companies covered
- Exhibit: companies covered in the report, 2021
- Top companies market positioning
- Exhibit: company positioning matrix, 2021
- Top companies market Share
- Exhibit: Pie chart analysis on company market share, 2021(%)
- Total number of companies covered
Methodology
For the Prostate Cancer Treatment Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:
1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.
2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Prostate Cancer Treatment Market.
3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.
4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.
Analyst Support
Customization Options
With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Prostate Cancer Treatment Market:
Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.
Regional Analysis: Further analysis of the Prostate Cancer Treatment Market for additional countries.
Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.
Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.
Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.
Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.
Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.
Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.
USA (+1) 351-333-4748
